Aralez Pharmaceuticals Inc Share Price Nasdaq
Equities
CA03852X1006
Pharmaceuticals
Sales 2016 | 54.27M 4.53B | Sales 2017 | 106M 8.85B | Capitalization | 94.98M 7.93B |
---|---|---|---|---|---|
Net income 2016 | -103M -8.6B | Net income 2017 | -125M -10.44B | EV / Sales 2016 | 9.18 x |
Net Debt 2016 | 209M 17.49B | Net Debt 2017 | 246M 20.51B | EV / Sales 2017 | 3.22 x |
P/E ratio 2016 |
-2.53
x | P/E ratio 2017 |
-0.75
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |